Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
7,600.00
+890.00 (13.26%)
At close: Jul 16, 2026
114.69% (1Y)
| Market Cap | 210.35B +114.7% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 125.96 |
| Forward PE | n/a |
| Dividend | 30.00 (0.39%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 23,630,505 |
| Open | 7,000.00 |
| Previous Close | 6,710.00 |
| Day's Range | 6,710.00 - 8,470.00 |
| 52-Week Range | 3,480.00 - 15,960.00 |
| Beta | 0.70 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |